Select for export Psilocybin: panacea or placebo? No abstract availability was recorded for this entry. Details DOI 10.1016/s2215-0366(16)30103-1 PubMed 27568263 Copy citation Copy BibTeX Unknown journal 2016-08-31 Hendrie C, Pickles A. Europe PMC Published psilocybin Depression Other More
Select for export Challenges in Laboratory Detection of Unusual Substance Abuse: Issues with Magic Mushroom, Peyote Cactus, Khat, and Solvent Abuse. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/bs.acc.2016.07.004 PubMed 28057187 Copy citation Copy BibTeX Unknown journal 2016-08-31 Dasgupta A. Europe PMC Published psilocybinpsilocin General Other More
Select for export Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881116662634 PubMed 27578767 Copy citation Copy BibTeX Journal of Psychopharmacology 2016-08-29 Carbonaro TM, Bradstreet MP, Barrett FS, MacLean KA, Jesse R, Johnson MW Europe PMC Published psilocybin WellbeingEmotional ProcessingObservational Study Observational Study More
Select for export It's time to take psilocybin seriously as a possible treatment for substance use disorders. No abstract availability was recorded for this entry. Details DOI 10.1080/00952990.2016.1200060 PubMed 27558746 Copy citation Copy BibTeX Unknown journal 2016-08-23 Bogenschutz MP. Europe PMC Published psilocybin Addiction Other More
Select for export Return of the psychedelics: Psilocybin for treatment resistant depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.ajp.2016.08.010 PubMed 27931907 Copy citation Copy BibTeX Unknown journal 2016-08-22 Patra S. Europe PMC Published psilocybin DepressionAddictionBrain Imaging Clinical Trial More
Select for export Psilocybin for treating substance use disorders? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/14737175.2016.1220834 PubMed 27684102 Copy citation Copy BibTeX Unknown journal 2016-08-11 de Veen BT, Schellekens AF, Verheij MM, Homberg JR. Europe PMC Published psilocybin DepressionAddictionMechanism of Action Clinical Trial More
Select for export Treating Addiction: Perspectives from EEG and Imaging Studies on Psychedelics. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/bs.irn.2016.06.005 PubMed 27503452 Copy citation Copy BibTeX Unknown journal 2016-07-24 Tófoli LF, de Araujo DB. Europe PMC Published psilocybin DepressionAddictionBrain Imaging Review Article More
Select for export Long-term follow-up of psilocybin-facilitated smoking cessation. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3109/00952990.2016.1170135 PubMed 27441452 Copy citation Copy BibTeX The American Journal of Drug and Alcohol Abuse 2016-07-20 Johnson MW, Garcia-Romeu A, Griffiths RR. Europe PMC Published psilocybin AddictionReceptor PharmacologySpirituality Other More
Select for export Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/ijnp/pyw016 PubMed 26874330 Copy citation Copy BibTeX The International Journal of Neuropsychopharmacology 2016-07-04 Maqueda AE, Valle M, Addy PH, Antonijoan RM, Puntes M, Coimbra J Europe PMC Published psilocybin AddictionMechanism of ActionReceptor Pharmacology Clinical Trial More
Select for export Antidepressant, Antipsychotic, and Hallucinogen Drugs for the Treatment of Psychiatric Disorders: A Convergence at the Serotonin-2A Receptor. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3928/02793695-20160616-09 PubMed 27362381 Copy citation Copy BibTeX Journal of Psychosocial Nursing and Mental Health Services 2016-06-30 Howland RH. Europe PMC Published psilocybin DepressionAnxietyPTSD Clinical Trial More
Select for export [Trends in Abuse of Biogenic Drugs in Parts of Germany 2007-2013]. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1055/s-0042-108644 PubMed 27300094 Copy citation Copy BibTeX Das Gesundheitswesen 2016-06-13 Pietsch J, Scheffel K, Acquarone D, Koch I, Deters M, Hermanns-Clausen M. Europe PMC Published psilocybin Adolescents Other More
Select for export Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.euroneuro.2016.05.001 PubMed 27216487 Copy citation Copy BibTeX Unknown journal 2016-05-19 Rickli A, Moning OD, Hoener MC, Liechti ME. Europe PMC Published psilocin Receptor PharmacologyAnimal StudyDrug Interactions Animal Study More
Select for export Commentary: Effects of psilocybin on time perception and temporal control of behavior in humans. No abstract availability was recorded for this entry. Details DOI 10.3389/fpsyg.2016.00736 PubMed 27242638 Copy citation Copy BibTeX Frontiers in Psychology 2016-05-18 Shebloski KL, Broadway JM. Europe PMC Published psilocybin General Other More
Select for export Sixty seconds on... psilocybin. No abstract availability was recorded for this entry. Details DOI 10.1136/bmj.i2775 PubMed 27194646 Copy citation Copy BibTeX BMJ 2016-05-17 Hawkes N. Europe PMC Published psilocybin Depression Other More
Select for export Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/s2215-0366(16)30065-7 PubMed 27210031 Copy citation Copy BibTeX The Lancet Psychiatry 2016-05-16 Carhart-Harris RL, Bolstridge M, Rucker J, Day CM, Erritzoe D, Kaelen M Europe PMC Published psilocybin DepressionAnxietyAddiction Other More
Select for export Altered states: psilocybin for treatment-resistant depression. No abstract availability was recorded for this entry. Details DOI 10.1016/s2215-0366(16)30087-6 PubMed 27210032 Copy citation Copy BibTeX Unknown journal 2016-05-16 Cowen P. Europe PMC Published psilocybin DepressionTreatment-Resistant Depression Other More
Select for export Effects of serotonin 2A/1A receptor stimulation on social exclusion processing. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1073/pnas.1524187113 PubMed 27091970 Copy citation Copy BibTeX Proceedings of the National Academy of Sciences 2016-04-17 Preller KH, Pokorny T, Hock A, Kraehenmann R, Stämpfli P, Seifritz E Europe PMC Published psilocybin Chronic PainBrain ImagingReceptor Pharmacology Clinical Trial More
Select for export Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/s2215-0366(15)00576-3 PubMed 27067625 Copy citation Copy BibTeX Unknown journal 2016-04-04 Mithoefer MC, Grob CS, Brewerton TD. Europe PMC Published psilocybin AnxietyPTSDAddiction Randomized Controlled Trial More
Select for export Psychedelics. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1124/pr.115.011478 PubMed 26841800 Copy citation Copy BibTeX Unknown journal 2016-03-31 Nichols DE. Europe PMC Published psilocybin DepressionAnxietyAddiction Clinical Trial More
Select for export Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/2045125316638008 PubMed 27354908 Copy citation Copy BibTeX Unknown journal 2016-03-17 Dos Santos RG, Osório FL, Crippa JA, Riba J, Zuardi AW, Hallak JE. Europe PMC Published psilocybin DepressionAnxietyAddiction Systematic Review More
Psilocybin-Research.com
Searchable psilocybin and psilocin bibliometric database.